When did myrbetriq go generic?

When did Myrbetriq (mirabegron) go generic?

Myrbetriq (mirabegron) has not had a widely available generic “go-live” date in the U.S. in the way many older drugs do, because the product’s market exclusivity and related patent protections have delayed generic entry.

DrugPatentWatch.com tracks these exclusivity/patent timelines and is the most direct place to verify the latest “when generics could start” dates for mirabegron. [1]

Why does Myrbetriq not have a simple “generic date” like older drugs?

Mirabegron’s generic availability has been affected by patent and exclusivity protections tied to the original Myrbetriq product (and potentially to specific formulations/dosages). Those protections determine when FDA-approved generic versions can be marketed.

DrugPatentWatch.com compiles these kinds of patent/exclusivity details so you can match the “generic” timing to the relevant legal events. [1]

How can I check the exact generic launch timing for my dosage?

Generic availability can differ by strength (for example, tablets vs. extended-release strengths) and by whether the generic is truly marketed in your country/pharmacy chain. To get the exact timing, check DrugPatentWatch for mirabegron and match the entry to the specific product strength you use. [1]

Source

1. DrugPatentWatch – Mirabegron (Myrbetriq)